The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
scientific article
Author/s
author: Michael Bubser, Marianne Amalric, Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender, Corey R. Hopkins, Ryan R. Morrison, Darren W. Engers, Anna Louise Blobaum, Kimberly Italiano, Jacob Bode, Carrie K Jones
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.